Tomasson, M.H.; Ali, M.; De Oliveira, V.; Xiao, Q.; Jethava, Y.; Zhan, F.; Fitzsimmons, A.M.; Bates, M.L.
Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma. Int. J. Mol. Sci. 2018, 19, 3621.
https://doi.org/10.3390/ijms19113621
AMA Style
Tomasson MH, Ali M, De Oliveira V, Xiao Q, Jethava Y, Zhan F, Fitzsimmons AM, Bates ML.
Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma. International Journal of Molecular Sciences. 2018; 19(11):3621.
https://doi.org/10.3390/ijms19113621
Chicago/Turabian Style
Tomasson, Michael H., Mahmoud Ali, Vanessa De Oliveira, Qian Xiao, Yogesh Jethava, Fenghuang Zhan, Adam M. Fitzsimmons, and Melissa L. Bates.
2018. "Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma" International Journal of Molecular Sciences 19, no. 11: 3621.
https://doi.org/10.3390/ijms19113621
APA Style
Tomasson, M. H., Ali, M., De Oliveira, V., Xiao, Q., Jethava, Y., Zhan, F., Fitzsimmons, A. M., & Bates, M. L.
(2018). Prevention Is the Best Treatment: The Case for Understanding the Transition from Monoclonal Gammopathy of Undetermined Significance to Myeloma. International Journal of Molecular Sciences, 19(11), 3621.
https://doi.org/10.3390/ijms19113621